Employees Retirement System of Texas’s Takeda Pharmaceutical TAK Stock Holding History

Employees Retirement System of Texas’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-93,257	Closed	-$1.36M	–	555
2025 Q3	$1.36M	Buy	+93,257	New	+$1.38M	0.01%	232
2025 Q2	–	Sell	-17,545	Closed	-$261K	–	559
2025 Q1	$261K	Buy	17,545 +11,915	+212%	+$167K	﹤0.01%	246
2024 Q4	$75K	Hold	5,630	–	–	﹤0.01%	305
2024 Q3	$80K	Buy	+5,630	New	+$79.9K	﹤0.01%	326
2024 Q2	–	Sell	-39,577	Closed	-$550K	–	352
2024 Q1	$550K	Hold	39,577	–	–	0.01%	293
2023 Q4	$565K	Hold	39,577	–	–	0.01%	294
2023 Q3	$612K	Hold	39,577	–	–	0.01%	263
2023 Q2	$622K	Hold	39,577	–	–	0.01%	282
2023 Q1	$652K	Hold	39,577	–	–	0.01%	286
2022 Q4	$617K	Buy	+39,577	New	+$553K	0.01%	307

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Employees Retirement System of Texas's TAK Position: Q4 2025 in Review

Employees Retirement System of Texas sold out of Takeda Pharmaceutical (TAK) in Q4 2025, closing a stake of 93,257 shares — an estimated $1.36M sold.

Employees Retirement System of Texas first reported a position in TAK in Q4 2022 and held it in 10 quarters. The position peaked at $1.36M in Q3 2025. 349 funds tracked by Wall St. Rank hold TAK as of Q4 2025.

Employees Retirement System of Texas reported no remaining Takeda Pharmaceutical position as of Q4 2025 after selling out during the quarter.
Employees Retirement System of Texas sold 93,257 Takeda Pharmaceutical shares in Q4 2025, an estimated $1.36M.
Employees Retirement System of Texas first reported a position in Takeda Pharmaceutical in Q4 2022 and held it in 10 quarters.
Employees Retirement System of Texas's Takeda Pharmaceutical position peaked at $1.36M in Q3 2025.
349 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2025.

Based on Employees Retirement System of Texas's 13F filing for Q4 2025, filed 9 Feb 2026.